INSR and hepatocellular carcinoma: Palmitic acid was previously shown to inhibit insulin pathway in hepatoma malignant cells (Zhang et al., (2012) depending on oxidation of the acyl-CoA which needs complete insulin receptor expression (Ruddock et al., 2008).